190 related articles for article (PubMed ID: 32974153)
21. Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia.
Ma M; Wang X; Tang J; Xue H; Chen J; Pan C; Jiang H; Shen S
Front Med; 2012 Dec; 6(4):416-20. PubMed ID: 23065427
[TBL] [Abstract][Full Text] [Related]
22. [Clinical analysis on adult acute T-lymphoblastic leukemia].
Zhang Q; Zhou CL; Fu MW; Wang JY; Lin D; Liu BC; Li W; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):478-82. PubMed ID: 22541122
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period.
Thomas X; Danaïla C; Le QH; Sebban C; Troncy J; Charrin C; Lhéritier V; Michallet M; Magaud JP; Fiere D
Leukemia; 2001 Dec; 15(12):1811-22. PubMed ID: 11753600
[TBL] [Abstract][Full Text] [Related]
24. A Comparative Analysis of Early T-Cell Precursor Lymphoblastic Leukemia/Lymphoma (ETP-ALL/LBL) and Non-ETP-ALL/LBL in a Tertiary Cancer Care Center Based in Western India.
Saha A; Brahmbhatt B; Rai V; Kakoty S; Sawhney J
Indian J Hematol Blood Transfus; 2023 Oct; 39(4):699-704. PubMed ID: 37786816
[TBL] [Abstract][Full Text] [Related]
25. Comparison of characteristics and outcomes on ETP-ALL/LBL and non-ETP ALL patients receiving allogeneic hematopoietic stem cell transplantation.
Chen J; Liu L; Ma R; Pang A; Yang D; Chen X; Wei J; He Y; Zhang R; Zhai W; Ma Q; Jiang E; Han M; Feng S
Front Oncol; 2022; 12():1025885. PubMed ID: 36686839
[TBL] [Abstract][Full Text] [Related]
26. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.
Fujisawa S; Mizuta S; Akiyama H; Ueda Y; Aoyama Y; Hatta Y; Kakihana K; Dobashi N; Sugiura I; Onishi Y; Maeda T; Imai K; Ohtake S; Miyazaki Y; Ohnishi K; Matsuo K; Naoe T
Am J Hematol; 2017 Apr; 92(4):367-374. PubMed ID: 28103625
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of Factors Influencing Prognosis of 87 Adults with Ph Chromosome Negative ALL].
Li J; Zhang ZB; Liu ZR; Yang M; Nie YX; Wu MM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1011-1015. PubMed ID: 30111399
[TBL] [Abstract][Full Text] [Related]
29. High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia.
Shigematsu A; Kobayashi N; Yasui H; Shindo M; Kakinoki Y; Koda K; Iyama S; Kuroda H; Tsutsumi Y; Imamura M; Teshima T
Biol Blood Marrow Transplant; 2014 Jun; 20(6):801-5. PubMed ID: 24565990
[TBL] [Abstract][Full Text] [Related]
30. Anti-CD19 chimeric antigen receptor-modified T-cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia: An open-label pragmatic clinical trial.
Jiang H; Li C; Yin P; Guo T; Liu L; Xia L; Wu Y; Zhou F; Ai L; Shi W; Lu X; Wang H; Tang L; Wei Q; Deng J; Jin R; Xiong W; Dong J; Mei H; Hu Y
Am J Hematol; 2019 Oct; 94(10):1113-1122. PubMed ID: 31321805
[TBL] [Abstract][Full Text] [Related]
31. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
[TBL] [Abstract][Full Text] [Related]
32. [Outcomes of younger than 60 years old adults with Ph/BCR-ABL positive acute lymphoblastic leukemia: a single center clinical trial of BDH ALL 2000/02].
Zhang YR; Wang TY; Zou DH; Sui WW; Li ZJ; Xu Y; Fu MW; Zhao YZ; Qi JY; Wang JX; Mi YC; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):493-7. PubMed ID: 23827104
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.
Candoni A; De Marchi F; Zanini F; Zannier ME; Simeone E; Toffoletti E; Chiarvesio A; Cerno M; Filì C; Patriarca F; Fanin R
Exp Hematol; 2017 May; 49():25-33. PubMed ID: 28159598
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of allogeneic stem cell transplantation for DLBCL: a multi-center study from the Kyoto Stem Cell Transplantation Group.
Izumi K; Kanda J; Nishikori M; Arai Y; Ishikawa T; Yoshioka S; Ueda Y; Maeda T; Yonezawa A; Anzai N; Moriguchi T; Imada K; Akasaka T; Nohgawa M; Itoh M; Aiba A; Tsunemine H; Watanabe M; Kondo T; Takaori-Kondo A
Ann Hematol; 2019 Dec; 98(12):2815-2823. PubMed ID: 31713653
[TBL] [Abstract][Full Text] [Related]
35. Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Nishiwaki S; Miyamura K; Ohashi K; Kurokawa M; Taniguchi S; Fukuda T; Ikegame K; Takahashi S; Mori T; Imai K; Iida H; Hidaka M; Sakamaki H; Morishima Y; Kato K; Suzuki R; Tanaka J;
Ann Oncol; 2013 Jun; 24(6):1594-602. PubMed ID: 23372050
[TBL] [Abstract][Full Text] [Related]
36. [Outcome of patients with adult acute lymphoblastic leukemia between 2000 and 2013: experience from single center].
Wang J; Jiang B; Liu K; Xu L; Zhang X; Chen H; Jia J; Yang S; Bao L; Jiang H; Lu J; Zhu H; Zhao T; Huang X; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):726-32. PubMed ID: 26462770
[TBL] [Abstract][Full Text] [Related]
37. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Santoro N; Ruggeri A; Labopin M; Bacigalupo A; Ciceri F; Gülbaş Z; Huang H; Afanasyev B; Arcese W; Wu D; Koc Y; Tischer J; Santarone S; Giebel S; Mohty M; Nagler A
J Hematol Oncol; 2017 May; 10(1):113. PubMed ID: 28558762
[TBL] [Abstract][Full Text] [Related]
38. Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patients.
Bommannan K; Arumugam JR; Radhakrishnan V; Kalaiyarasi JP; Karunakaran P; Mehra N; Sagar TG; Sundersingh S
Blood Res; 2022 Sep; 57(3):175-196. PubMed ID: 35880498
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lou Y; Ma Y; Li C; Suo S; Tong H; Qian W; Mai W; Meng H; Yu W; Mao L; Wei J; Xu W; Jin J
Front Med; 2017 Jun; 11(2):229-238. PubMed ID: 28349299
[TBL] [Abstract][Full Text] [Related]
40. Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITD.
Labouré G; Dulucq S; Labopin M; Tabrizi R; Guérin E; Pigneux A; Lafarge X; Leguay T; Bouabdallah K; Dilhuydy MS; Duclos C; Lascaux A; Marit G; Mahon FX; Boiron JM; Milpied N; Vigouroux S
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1845-50. PubMed ID: 22766221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
